TMCnet News
Research and Markets: Hypercholesterolemia Partnering Deals and Agreements Analysis 2010-2015Research and Markets (http://www.researchandmarkets.com/research/tps7bz/hypercholesterolem) has announced the addition of the "Hypercholesterolemia Partnering 2010-2015" report to their offering. The Hypercholesterolemia Partnering 2010-2015 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypercholesterolemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hypercholesterolemia technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered- contract documents provide this insight where press releases do not. This data driven report contains over 50 links to online copies of actual hypercholesterolemia deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. Report scope This data driven report includes:
In Hypercholesterolemia Partnering 2010-2015, the available deals are listed by:
Companies Mentioned
For more information visit http://www.researchandmarkets.com/research/tps7bz/hypercholesterolem
|
